PROCEPT BioRobotics (PRCT) Trading at 4.5x Sales Amid Growth

AI Summary

As of June 17, PROCEPT BioRobotics Corporation (PRCT) shares traded at $20.91. The company reported quadrupled revenues since 2022, currently growing at approximately 30% year-over-year. Despite this growth, PRCT trades at 4.5 times sales, while peers like Intuitive Surgical (ISRG) previously traded in a range of 9-18 times sales. Analysts project that PRCT could see approximately 150% appreciation over three years if growth patterns similar to ISRG continue, although short-term sentiment remains mixed due to slightly below-expectation revenue guidance.